Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Point-of-Care Ultrasonography in a Pulmonary Hypertension Clinic: A Randomized Pilot Study

View through CrossRef
Pulmonary arterial hypertension (PAH) is a rare condition with the potential to progress to right heart failure. Point-of-Care Ultrasonography (POCUS), used and interpreted in real time at the bedside to further the cardiopulmonary assessment, has the potential to improve the longitudinal care of PAH patients in the ambulatory setting. Patients from PAH clinics at two academic medical centers were randomized to either a POCUS assessment cohort or non-POCUS standard care (ClinicalTrials.gov identifier NCT05332847). The POCUS group received blinded heart, lung, and vascular ultrasound assessments. Thirty-six patients were randomized to the study and followed over time. Mean age was 65 in both groups and majority female (76.5% and 88.9% females in POCUS and control, respectively). Median time for POCUS assessment was 11 min (range 8–16). There were significantly more changes in management in the POCUS group than control (73% vs. 27%, p-value < 0.001). Multivariate analysis revealed that management changes were more likely to occur with a POCUS assessment, with an odds ratio (OR) of 12 when POCUS was added to physical exam vs. OR of 4.6 compared to physical examination alone (p < 0.001). POCUS in the PAH clinic is feasible and, when combined with physical examination, increases the number of findings and results in changes in management without significantly prolonging visit encounters. POCUS may help support clinical evaluation and decision making in ambulatory PAH clinics.
Title: Point-of-Care Ultrasonography in a Pulmonary Hypertension Clinic: A Randomized Pilot Study
Description:
Pulmonary arterial hypertension (PAH) is a rare condition with the potential to progress to right heart failure.
Point-of-Care Ultrasonography (POCUS), used and interpreted in real time at the bedside to further the cardiopulmonary assessment, has the potential to improve the longitudinal care of PAH patients in the ambulatory setting.
Patients from PAH clinics at two academic medical centers were randomized to either a POCUS assessment cohort or non-POCUS standard care (ClinicalTrials.
gov identifier NCT05332847).
The POCUS group received blinded heart, lung, and vascular ultrasound assessments.
Thirty-six patients were randomized to the study and followed over time.
Mean age was 65 in both groups and majority female (76.
5% and 88.
9% females in POCUS and control, respectively).
Median time for POCUS assessment was 11 min (range 8–16).
There were significantly more changes in management in the POCUS group than control (73% vs.
27%, p-value < 0.
001).
Multivariate analysis revealed that management changes were more likely to occur with a POCUS assessment, with an odds ratio (OR) of 12 when POCUS was added to physical exam vs.
OR of 4.
6 compared to physical examination alone (p < 0.
001).
POCUS in the PAH clinic is feasible and, when combined with physical examination, increases the number of findings and results in changes in management without significantly prolonging visit encounters.
POCUS may help support clinical evaluation and decision making in ambulatory PAH clinics.

Related Results

Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Hypertension poses a significant global burden due to low adherence to antihypertensive medications. Hypertension treatment aims to bring blood pressure within physiological ranges...
Pulmonary hypertension associated with left-sided heart disease
Pulmonary hypertension associated with left-sided heart disease
Pulmonary hypertension associated with left-sided heart disease (PH-LHD) is the most common type of pulmonary hypertension. In patients with left-sided heart disease, the presence ...
Respiratory rate modulation improves symptoms in patients with pulmonary hypertension
Respiratory rate modulation improves symptoms in patients with pulmonary hypertension
Background: Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension are chronic diseases with a severe symptom burden. Common symptoms are dyspnoea at lig...
Evaluation of pulmonary hypertension and its relationship with serum parathyroid hormone levels in hemodialysis patients
Evaluation of pulmonary hypertension and its relationship with serum parathyroid hormone levels in hemodialysis patients
Introduction: Pulmonary hypertension is a progressive and severe disease associated with left or right ventricular dysfunction and is common in patients under hemodialysis. One of ...
526 ALAGILLE SYNDROME, A CASE REPORT
526 ALAGILLE SYNDROME, A CASE REPORT
Abstract Alagille syndrome (AGS) is a dominantly inherited multisystem disorder caused by heterozygous mutations of genes that are components of the Notch signaling ...
Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects.
Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects.
In patients with pulmonary hypertension associated with congenital heart defects, ultrastructural abnormalities are observed in endothelial cells, which suggest heightened metaboli...
Principles of pharmacological correction of pulmonary arterial hypertension
Principles of pharmacological correction of pulmonary arterial hypertension
Definition and classification: Pulmonary hypertension (PH) is a group of life-threatening progressive diseases of various genesis, characterized by a progressive increase in arteri...

Back to Top